Evolv Technologies Holdings, Inc. filings document the public-company disclosures of an AI-based security screening business with Class A common stock and warrants listed on Nasdaq. Its Form 8-K reports include financial-results releases, Regulation FD disclosures, board and officer changes, stockholder meeting results, credit-agreement disclosures and registration-statement amendments tied to resale securities and warrant exercises.
Proxy materials describe director elections, executive compensation, auditor ratification, board committee matters and shareholder voting procedures. The filings also identify capital-structure elements, including Class A common stock, warrants and subsidiary borrowing arrangements, alongside governance and reporting matters for Evolv’s screening technology operations.
Director Mark J. Sullivan of Evolv Technologies Holdings (EVLV) received a grant of 27,050 Restricted Stock Units (RSUs) on June 20, 2025. Each RSU represents the right to receive one share of Class A common stock.
Key terms of the RSU grant:
- The RSUs will fully vest on the earlier of June 20, 2026 or the day before the next annual meeting
- The RSUs were granted at no cost ($0)
- The securities are held in direct ownership
- The RSUs have no expiration date
This Form 4 filing was submitted by Rachel Roy as attorney-in-fact for Mark Sullivan on June 24, 2025, within the required reporting window for insider transactions.
Evolv Technologies Holdings, Inc. (EVLV) – Form 4 Insider Transaction
Director Bilal Zuberi reported the receipt of 27,050 Restricted Stock Units (RSUs) on 20 June 2025. Each RSU converts into one share of EVLV Class A common stock upon vesting. The award will vest in full on the earlier of 20 June 2026 or the day immediately preceding the company’s next annual shareholder meeting. No cash was paid for the RSUs (exercise price = $0), and there is no expiration date.
Following the grant, Zuberi beneficially owns 27,050 derivative securities; no additional non-derivative share holdings were disclosed in this filing. The filing reflects standard equity compensation for board members and does not indicate any share sales or purchases in the open market.
Given EVLV’s public float, the share count involved is immaterial from a dilution standpoint, but the award reinforces director/shareholder alignment without immediate cash outflow by the company.
Evolv Technologies Holdings (EVLV) reported a Form 4 filing disclosing an insider transaction by Director David Mounts Gonzales on June 20, 2025. The director was granted 27,050 Restricted Stock Units (RSUs) as part of the company's equity compensation plan.
Key details of the RSU grant:
- Each RSU represents a right to receive one share of Class A common stock
- The RSUs were granted at $0 cost to the director
- Vesting will occur in full at the earlier of June 20, 2026 or the day before the next annual meeting
- The RSUs have no expiration date
This transaction appears to be part of standard director compensation arrangements. The filing was signed by Rachel Roy as attorney-in-fact for David Mounts Gonzales on June 24, 2025.